PATH

Grantee Website Seattle, Washington, United States
Purpose
to identify species-conserved Group B Streptococcus proteins to be used as carrier proteins in the low-cost hexavalent GBS conjugate vaccine under development at Biovac
Division
Global Health
Date
NOVEMBER 2018
Region Served
GLOBAL
Committed Amount
$1,767,573
Grant Topic
Pneumonia
Duration (Months)
36
Grantee Location
Seattle, Washington, United States

More about our work

Our story

Learn about the origins of the foundation and the values that drive our work.

Our work

Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.

How we work

We are focused on results. Those that can be measured. And those measured in ways beyond numbers.